Resistance in the Genes: Why Popular Obesity Drugs Don’t Work for Everyone
GLP-1 receptor agonists like Wegovy and Mounjaro have fundamentally reshaped the treatment of diabetes and obesity.
Biowatch
New Biologic Drug Lands in Korea: Expanded Relief for Chronic Rhinosinusitis and Nasal Polyps
A biologic medication previously recognized for its effectiveness in treating severe asthma is now offering a new therapeutic path for patients...
A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions
Truxima , a blood cancer treatment developed by Celltrion, has become the first Korean-made biosimilar to rank number...
The Protein That Erodes Memory: Is ‘Ftl1’ the Key to Reversing Brain Aging?
Why does memory fade and the mind slow as the years pass. Addressing this ancient question, a U. S.
Rznomics and Inha University Confirm Potential for In-Vivo CAR-T Delivery Technology
Rznomics announced on the 30th that a joint study with Professor Hyun-jin Kim’s research team at Inha University has...
Will Curocell’s First CAR-T Blood Cancer Drug Secure Approval Next Month?
A final decision on the approval of RIMQARTO (anbalcabtagene autoleucel), a chimeric antigen receptor T-cell (CAR-T)...
YuhanUSA and Huinno Partner to Launch AI-Powered ECG Monitoring in the U.S.
YuhanUSA, the U.S. subsidiary of Yuhan Corporation, announced on the 30th that it has signed a strategic business...
A Major Paradigm Shift in Cholesterol Management: Earlier Testing, 30-Year Risk Predictions
Heart disease often appears as a sudden crisis, but it is typically the result of risks that have quietly accumulated...
Vabysmo Prefilled Syringe Gains Reimbursement, Expanding Retina Treatment Options
Injectable therapies for chronic eye diseases are entering a new era where clinicians and patients can select...
Sam Chun Dang Pharm Secures Exclusive U.S. Licensing Deal for Oral Obesity and Diabetes Treatment
Sam Chun Dang Pharm has entered into a significant license-out agreement with an undisclosed U. S.